Delivery Order SPE2DB22D2007-SPE2DB24FJ3WH

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $14,131.38 Firm Fixed Price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of 4,563,816,815 units of the prescription drug PROMACTA 50 MG TABLET. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $7,242.58, is for the delivery of PROMACTA 50 MG TABLET prescription medication to support military treatment programs and facilities. The contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,242.58 firm fixed-price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product, to support various government healthcare programs. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
The Defense Logistics Agency awarded a $7,997.74 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of PROMACTA 25 MG SUSPENSION PCKT 30S. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,026.53 for the supply of PROMACTA 50 MG TABLET UU 30S. The contract has an ultimate completion date of July 17, 2025 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,251.75 firm-fixed-price delivery order is for the supply of PROMACTA 12.5 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $20,056.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROMACTA 75 MG TABLET UU 30S, a pharmaceutical product, and has an ultimate completion date of April 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,242.58 firm fixed-price delivery order is for the supply of 4564766040 PROMACTA 50 MG TABLET UU 30S, with a completion date of June 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 Firm Fixed Price delivery order is for the drug Promacta 50 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,227.06 firm fixed-price delivery order contract is for the supply of PROMACTA 75 MG TABLET medication. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3WH
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,242.58 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of PROMACTA 50 MG TABLET (National Drug Code 4565046823) and has a completion date of July 23, 2024.

AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract award did not utilize any set-aside designations.

Generated 10/1/24, 5:12 PM